Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases

NCT05620914 is registered in ClinicalTrials.gov with Mustafa Khasraw, MBChB, MD, FRCP, FRACP as lead sponsor.

NCT NCT05620914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05620914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases
Lead sponsor
Mustafa Khasraw, MBChB, MD, FRCP, FRACP
Phase
Phase 2
Overall status
Withdrawn
Start date
July 31, 2025
Completion date
April 30, 2027
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, adult